Timing of maintenance therapy for leukaemia

Clinical heterogeneity in childhood acute lymphoblastic leukemia with 11q23 rearrangements.

Leukemia·2003

A pediatric approach to the WHO classification of myelodysplastic and myeloproliferative diseases.

Leukemia·2003

Clinical features, cytogenetics and outcome in acute lymphoblastic and myeloid leukaemia of infancy: report from the MRC Childhood Leukaemia working party.

Leukemia·2002

Treatment of infants with lymphoblastic leukaemia: results of the UK Infant Protocols 1987-1999.

British journal of haematology·2002

Outcome for children after failed transplant for primary haemophagocytic lymphohistiocytosis.

British journal of haematology·2002

Down's syndrome and acute lymphoblastic leukaemia: clinical features and response to treatment.

Archives of disease in childhood·2001

Efficacy and safety of upadacitinib in adults and adolescents for treatment of non-segmental vitiligo (Viti-Up): results of two phase 3 randomised controlled studies.

Lancet (London, England)·2026

Belzutifan plus lenvatinib versus cabozantinib in patients with previously treated advanced renal cell carcinoma (LITESPARK-011): an open-label, randomised, controlled, phase 3 trial.

Lancet (London, England)·2026

Switch to once-weekly, single-tablet islatravir-lenacapavir from daily standard of care for HIV-1 (ISLEND-2): a multicentre, randomised, open-label, active-controlled, phase 3 non-inferiority trial.

Lancet (London, England)·2026

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Lancet (London, England)·2026

Tetracycline-loaded nanomotors target neutrophil activation and oxidative stress in acute lung injury.

iScience·2026

Self-reported side effects of tattooing: a cross-sectional study in the Swedish TABOO cohort.

BMJ public health·2026

Development of cecal volvulus after redo pancreas transplantation.

Journal of surgical case reports·2026

Primary Diffuse Large B-Cell Lymphoma of the External Auditory Canal with Extensive Local Extension: A Case Report and Literature Review.

Iranian journal of otorhinolaryngology·2026

Early Changes in the Neutrophil-to-Lymphocyte Ratio are Associated with Conversion Outcomes in Advanced Hepatocellular Carcinoma Treated with HAIC-Based Triple Therapy.

Journal of hepatocellular carcinoma·2026

Comparison of variably specific Bruton tyrosine kinase inhibitors on platelet aggregation mediated by Fcγ receptor (FcγR) IIa, glycoprotein VI, and platelet endothelial aggregation receptor (PEAR) 1: implications for Bruton tyrosine kinase inhibitors as antithrombotic therapy.

Research and practice in thrombosis and haemostasis·2026

Related Experiment Videos

Timing of maintenance therapy for leukaemia

Related Concept Videos

Clinical heterogeneity in childhood acute lymphoblastic leukemia with 11q23 rearrangements.

A pediatric approach to the WHO classification of myelodysplastic and myeloproliferative diseases.

Clinical features, cytogenetics and outcome in acute lymphoblastic and myeloid leukaemia of infancy: report from the MRC Childhood Leukaemia working party.

Treatment of infants with lymphoblastic leukaemia: results of the UK Infant Protocols 1987-1999.

Outcome for children after failed transplant for primary haemophagocytic lymphohistiocytosis.

Down's syndrome and acute lymphoblastic leukaemia: clinical features and response to treatment.

Efficacy and safety of upadacitinib in adults and adolescents for treatment of non-segmental vitiligo (Viti-Up): results of two phase 3 randomised controlled studies.

Belzutifan plus lenvatinib versus cabozantinib in patients with previously treated advanced renal cell carcinoma (LITESPARK-011): an open-label, randomised, controlled, phase 3 trial.

Switch to once-weekly, single-tablet islatravir-lenacapavir from daily standard of care for HIV-1 (ISLEND-2): a multicentre, randomised, open-label, active-controlled, phase 3 non-inferiority trial.

[177Lu]Lu-PSMA-617 in patients with PSMA-positive metastatic androgen pathway modulator-naive/sensitive prostate cancer (PSMAddition): a phase 3 randomised, controlled trial.

Tetracycline-loaded nanomotors target neutrophil activation and oxidative stress in acute lung injury.

Self-reported side effects of tattooing: a cross-sectional study in the Swedish TABOO cohort.

Development of cecal volvulus after redo pancreas transplantation.

Primary Diffuse Large B-Cell Lymphoma of the External Auditory Canal with Extensive Local Extension: A Case Report and Literature Review.

Early Changes in the Neutrophil-to-Lymphocyte Ratio are Associated with Conversion Outcomes in Advanced Hepatocellular Carcinoma Treated with HAIC-Based Triple Therapy.

Comparison of variably specific Bruton tyrosine kinase inhibitors on platelet aggregation mediated by Fcγ receptor (FcγR) IIa, glycoprotein VI, and platelet endothelial aggregation receptor (PEAR) 1: implications for Bruton tyrosine kinase inhibitors as antithrombotic therapy.

Related Experiment Videos

Timing of maintenance therapy for leukaemia

Related Concept Videos

Related Articles